Comparative effectiveness of sildenafil citrate and estradiol valerate as adjuvants during clomiphene citrate-assisted ovarian stimulation cycles in patients with unexplained infertility: a double-blind randomized controlled trial
Open Access
- 9 October 2024
- journal article
- research article
- Published by Springer Nature in Contraception and Reproductive Medicine
- Vol. 9 (1) , 1-12
Abstract
This study aimed to assess the effect of sildenafil citrate and estradiol valerate as adjuvant therapy during ovarian stimulation cycles with clomiphene citrate in patients with unexplained infertility in Kisangani. A double-blind, randomized controlled trial was conducted for two years at two specialized health facilities in Kisangani (University Clinics of Kisangani and “Clinique des Anges Kisangani”). The population included 148 patients, 74 of whom were on clomiphene citrate + sildenafil citrate (CCSC) regimens and 74 of whom were on clomiphene citrate + estradiol valerate (CCEV) regimens for three months. The primary indicator was the conception rate, with secondary outcomes encompassing endometrial thickness, appearance and vascularity, the number of mature follicles and ovulation rate. The two groups were comparable in terms of sociodemographic and clinical characteristics. The mean duration of attempting to conceive was 4.39 years versus 4.36 years (P = 0.839), while the mean AFC was 11.51 versus 11.46 (P = 0.831), in the CCSC group versus CCEV group respectively. Secondary infertility was the most frequent diagnosis in each of the two groups. The biochemical pregnancy rate was comparable between the two groups (P = 0.385), while the clinical pregnancy rate was significantly higher in the CCSC group versus CCEV group (P = 0.04). Both perifollicular flow and the ovulation rate were significantly higher in the CCSC group versus the CCEV group (P = 0.006 and P = 0.002 respectively). However, endometrial vascularity/thickness, and the number of Graafian follicles were not significantly different between the two groups. As an adjuvant, sildenafil increases the rate of clinical pregnancy more than does estradiol in patients with unexplained infertility undergoing ovarian stimulation with clomiphene citrate. PACTR 202,310,849,449,401 (Pan African Clinical Trials Registry).Keywords
All Related Versions
This publication has 54 references indexed in Scilit:
- A randomized clinical trial of sildenafil plus clomiphene citrate to improve the success rate of ovulation induction in patients with unexplained infertilityInternational Journal of Gynecology & Obstetrics, 2020
- Evidence-based treatments for couples with unexplained infertility: a guidelineFertility and Sterility, 2020
- Vasodilators for women undergoing fertility treatmentCochrane Database of Systematic Reviews, 2018
- Counting ovarian antral follicles by ultrasound: a practical guideUltrasound in Obstetrics & Gynecology, 2017
- Detection of ovulation, a review of currently available methodsBioengineering & Translational Medicine, 2017
- Evidence-based approach to unexplained infertility: a systematic reviewFertility and Sterility, 2016
- Vitamin E effect on controlled ovarian stimulation of unexplained infertile womenJournal of Assisted Reproduction and Genetics, 2012
- Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndromeFertility and Sterility, 2009
- Sildenafil citrate decreased natural killer cell activity and enhanced chance of successful pregnancy in women with a history of recurrent miscarriageFertility and Sterility, 2008
- Relationship between endometrial thickness and embryo implantation, based on 1,294 cycles of in vitro fertilization with transfer of two blastocyst-stage embryosFertility and Sterility, 2007